Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020;58(6):343-344.
doi: 10.5114/reum.2020.101998. Epub 2020 Dec 23.

Advances in diagnostics and therapy of systemic amyloidoses

Krzysztof Jamroziak  1   2 , Bartosz Puła  1
Affiliations
Editorial

Advances in diagnostics and therapy of systemic amyloidoses

Krzysztof Jamroziak et al. Reumatologia. 2020.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387:2641–2654. doi: 10.1016/S0140-6736(15)01274-X. - DOI - PubMed
    1. Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219. doi: 10.1080/13506129.2018.1549825. - DOI - PubMed
    1. Aljaroudi WA, Desai MY, Tang WH, et al. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. J Nucl Cardiol. 2014;21:271–283. - PubMed
    1. Jamroziak K, Milani P, Puła B, et al. Diagnostyka i leczenie amyloidozy AL. Hematologia. 2018;9:181–195. doi: 10.5603/Hem.2018.0024. - DOI
    1. Palladini G, Kastritis E, Maurer MS, et al. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood. 2020;136:71–80. doi: 10.1182/blood.2019004460. - DOI - PMC - PubMed

Publication types